The role of IL-6/JAK2/STAT3 signaling pathway in cancers

B Huang, X Lang, X Li - Frontiers in oncology, 2022 - frontiersin.org
Interleukin-6 (IL-6) is a pleiotropic cytokine involved in immune regulation. It can activate
janus kinase 2 (JAK2)-signal transducer and activator of transcription 3 (STAT3) signaling …

Inflammation and pancreatic cancer: focus on metabolism, cytokines, and immunity

A Padoan, M Plebani, D Basso - International journal of molecular …, 2019 - mdpi.com
Systemic and local chronic inflammation might enhance the risk of pancreatic ductal
adenocarcinoma (PDAC), and PDAC-associated inflammatory infiltrate in the tumor …

The therapeutic landscape of rheumatoid arthritis: current state and future directions

S Shams, JM Martinez, JRD Dawson, J Flores… - Frontiers in …, 2021 - frontiersin.org
Rheumatoid arthritis (RA) is a debilitating autoimmune disease with grave physical,
emotional and socioeconomic consequences. Despite advances in targeted biologic and …

Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives

E Khatoon, K Banik, C Harsha, BL Sailo… - Seminars in Cancer …, 2022 - Elsevier
Despite significant advancements made in the treatment of cancer during the past several
decades, it remains one of the leading causes of death worldwide killing approximately 9.6 …

[HTML][HTML] IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human …

W Zhang, Y Liu, Z Yan, H Yang, W Sun… - … for immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Background We have previously discovered a relationship between the low expression of
protein tyrosine phosphatase, receptor type O (PTPRO) in tumor-infiltrating T cells and …

[HTML][HTML] Systematic literature review of IL-6 as a biomarker or treatment target in patients with gastric, bile duct, pancreatic and colorectal cancer

N Vainer, C Dehlendorff, JS Johansen - Oncotarget, 2018 - ncbi.nlm.nih.gov
Gastrointestinal cancer (GI) is a major health problem. Patients with gastric, pancreatic,
colorectal, bile duct and gall bladder cancer often have advanced disease at the time of …

Emerging roles for the IL-6 family of cytokines in pancreatic cancer

G van Duijneveldt, MDW Griffin, TL Putoczki - Clinical science, 2020 - portlandpress.com
Pancreatic cancer has one of the poorest prognoses of all malignancies, with little
improvement in clinical outcome over the past 40 years. Pancreatic ductal adenocarcinoma …

Methamphetamine and its immune-modulating effects

M Papageorgiou, A Raza, S Fraser, K Nurgali… - Maturitas, 2019 - Elsevier
The recreational use of methamphetamine (METH, or ice) is a global burden. It pervades
and plagues contemporary society; it has been estimated that there are up to 35 million …

[HTML][HTML] Ginger polysaccharide UGP1 suppressed human colon cancer growth via p53, Bax/Bcl-2, caspase-3 pathways and immunomodulation

Y Qian, C Shi, C Cheng, D Liao, J Liu… - Food Science and Human …, 2023 - Elsevier
In previous study, we got a purified ginger polysaccharide UGP1 and verified its significant
antitumor activities on colon cancer HCT116 cells. In this article, we aimed to illustrate the …

Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis

W Li, L Sun, J Lei, Z Wu, Q Ma… - Oncology …, 2020 - spandidos-publications.com
Hypoxic microenvironment and pancreatic stellate cells (PSCs) play important roles in
pancreatic cancer progression. PSCs secrete a number of soluble factors, such as …